Citation: H. Schott, Effect of inorganic additives on solutions of nonionic surfactants - XVI. Limiting cloud points of highly polyoxyethylated surfactants, COLL SURF A, 186(1-2), 2001, pp. 129-136
Authors:
Schwendener, RA
Friedl, K
Depenbrock, H
Schott, H
Hanauske, AR
Citation: Ra. Schwendener et al., In vitro activity of liposomal N(4)octadecyl-1-beta-D-arabinofurano-sylcytosine (NOAC), a new lipophilic derivative of 1-beta-D-arabino-furanocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells, INV NEW DR, 19(3), 2001, pp. 203-210
Authors:
Atzpodien, J
Kirchner, H
Illiger, HJ
Metzner, B
Ukena, D
Schott, H
Funke, PJ
Gramatzki, M
von Jurgensom, S
Wandert, T
Patzelt, T
Reitz, M
Citation: J. Atzpodien et al., IL-2 in combination with IFN-alpha and 5-FU versus tamoxifen in metastaticrenal cell carcinoma: long-term results of a controlled randomized clinical trial, BR J CANC, 85(8), 2001, pp. 1130-1136
Authors:
Cattaneo-Pangrazzi, RMC
Schott, H
Schwendener, RA
Citation: Rmc. Cattaneo-pangrazzi et al., The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent humanprostate cancer cell lines PC-3 and DU-145, PROSTATE, 45(1), 2000, pp. 8-18
Authors:
Horber, DH
Cattaneo-Pangrazzi, RMC
von Ballmoos, P
Schott, H
Ludwig, PS
Eriksson, S
Fichtner, I
Schwendener, RA
Citation: Dh. Horber et al., Cytotoxicity, cell-cycle perturbations and apoptosis in human tumor cells by lipophilic N-4-alkyl-1-beta-D-arabinofuranosylcytosine derivatives and the new heteronucleoside phosphate dimer arabinocytidylyl-(5 '-> 5 ')-N-4-octadecyl-1-beta-D-arabinofuranosylcytosine, J CANC RES, 126(6), 2000, pp. 311-319
Authors:
Cattaneo-Pangrazzi, RMC
Schott, H
Wunderli-Allenspach, H
Rothen-Rutishauser, B
Guenthert, M
Schwendener, RA
Citation: Rmc. Cattaneo-pangrazzi et al., Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells, J CANC RES, 126(5), 2000, pp. 247-256
Authors:
Cattaneo-Pangrazzi, RMC
Schott, H
Wunderli-Allenspach, H
Derighetti, M
Schwendener, RA
Citation: Rmc. Cattaneo-pangrazzi et al., Induction of cell cycle-dependent cytotoxicity and apoptosis by new heterodinucleoside phosphate dimers of 5-fluorodeoxyuridine in PC-3 human prostate cancer cells, BIOCH PHARM, 60(12), 2000, pp. 1887-1896
Authors:
Schwendener, RA
Peghini, PA
Ludwig, PS
Schott, H
Citation: Ra. Schwendener et al., Synthesis, in vitro anti-HIV and anti-hepatitis B activities and pharmacokinetic properties of amphiphilic heterodinucleoside phosphates containing ddC and AZT, NUCLEOS NUC, 18(4-5), 1999, pp. 949-950
Citation: H. Schott, The clavichord collection, Vol 1, Bach 'French Suites' and Purcell, Vol 2,J.J. Froberger & early English pieces - JMSCD-4/5 (Dart), EARLY MUSIC, 27(4), 1999, pp. 678-680
Authors:
Schott, H
Ludwig, PS
Immelmann, A
Schwendener, RA
Citation: H. Schott et al., Synthesis and in vitro anti-HIV activities of amphiphilic heterodinucleoside phosphate derivatives containing the 2 ',3 '-dideoxynucleosides ddC, AZTand ddI, EUR J MED C, 34(4), 1999, pp. 343-352
Authors:
Koller-Lucae, SKM
Suter, MJF
Rentsch, KM
Schott, H
Schwendener, RA
Citation: Skm. Koller-lucae et al., Metabolism of the new liposomal anticancer drug N-4-octadecyl-1-beta-D-arabinofuranosylcytosine in mice, DRUG META D, 27(3), 1999, pp. 342-350
Authors:
Koller-Lucae, SKM
Schott, H
Schwendener, RA
Citation: Skm. Koller-lucae et al., Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N-4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells, BR J CANC, 80(10), 1999, pp. 1542-1549